Skip to main content

Patient notice – Tirzepatide (Mounjaro)

We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.

Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.

Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.

Copyright

The contents of the site are protected by copyright law. Copyright law and patent law may protect various software, programming and scripts in use by Silicon Practice. Text, graphics, appearance, visual elements, design, concepts, conceptual models, business models, operational models, databases, collections of links, hyper text markup language (HTML) code, scripts and all products sold and services offered are protected by Copyright Laws and Treaties, and may not be copied, published, reengineered, decompiled, translated, mirrored, hosted, or otherwise distributed by any means without explicit written permission of Silicon Practice.

Trademarks appearing on the site are protected by law and you cannot use any such trademarks in any fashion without the express written permission of the trademark owner.

The textual content of this site is the copyright of the practice.

Contains public sector information licensed under the Open Government Licence v3.0.

Page published: 5 May 2023
Last updated: 15 April 2024